Burns
Volume 31, Issue 5 , Pages 562-567 , August 2005

A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: Comparative patient care audits

,Accepted 15 December 2004.

References 

  1. Peck M, Weber J, McManus A, Sheridan R, Heimbach D. Surveillance of burn wound infection: a proposal for definitions. J Burn Care Rehabil. 1998;19:386–389
  2. Barlow Y. T lymphocytes, immunosuppression in the burned patient: a review. Burns. 1994;20(6):470–487
  3. Miller M. How do I diagnose and treat wound infection. Br J Nurs. 1998;7(6):335–338
  4. Ayton M. Wounds that won’t heal. Nurs Times. 1985;81(46):16–19
  5. Heggers J, Hawkins H, Edgar P, Villareal C, Herndon D. Treatment of infection in burns. In:  Herndon DN editors. Total burn care. 2nd ed.. London: Saunders; 2002;p. 136
  6. Landsdown A. Silver 1: its antibacterial properties and mechanism of action. J Wound Care. 2002;11(4):125–130
  7. Kumar G, Rameshwar L, Suhas C, Eiman M, Abdul R. Pseudomonas aeruginosa septicaemia in burns. Burns. 1999;25:611–616
  8. Cook N. Methicillin resistant Staphylococcus aureus versus the burned patient. Burns. 1998;24:91–98
  9. Douglas W, Mulholland K, Denyer V, Gottlieb T. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit-an infection control study. Burns. 2001;27(2):131–135
  10. Tredget E, Shankovsky R, Groenveld A, Burrell R. A matched-pair, randomised study evaluating the efficacy and safety of Acticoat* silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998;19(6):531–537
  11. Sheridan R, Petera L, Lydon M, Salvo F. Once-daily wound cleansing and dressing change: efficacy and cost. J Burn Care Rehabil. 1997;18:139–140
  12. Quarmby C, Rode H. The cost of cost-savings. Prim Intention. 2003;11(1):19–22
  13. Demling R, DeSanti L. Part 1: effects of silver on wound management. Wounds. Compendium Clin Res Pract. Suppl. A. 2001;13(1):4–15
  14. Wright J, Lam K, Burrell R. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998;26:572–577
  15. Thomas S. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care. 2003;12(3):101–107
  16. Thomas S. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care. 2003;12(8):305–309
  17. Yin H, Langford R, Burrell R. Comparative evaluation of the antimicrobial action of Acticoat* antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20(3):195–199
  18. Fraser J, Bodman J, Sturgess R, Faogali J, Kimble R. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine. Burns. 2004;30(1):35–41
  19. Innes M, Umraw N, Fish J, Gomez M, Cartotto R. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns. 2001;27:621–627
  20. Garner J, Jarvis W, Wmori E, Horan T, Hughes J. CDC definitions of nosocomial infections. Am J Infect Control. 1988;16:128–140
  21. Miller P, Matthey F. A cost-benefit analysis of initial burn cultures in the management of acute burns. J Burn Care Rehabil. 2000;21(4):300–304
  22. Landsdown A. Silver 2: toxicity in mammals and how its products aid wound repair. J Wound Care. 2002;11(5):73–177
  23. Precht R, Burrell R. A comparative analysis of the anti-microbial efficacy of a novel silver coated dressing, a silver sulfadiazine and silver nitrate. J Burn Care Rehabil. 1997;18:178
  24. Fuller F, Engler P. Leukopenia in non-septic patients receiving 1% silver sulphadiazine cream treatment: a survey. J Burn Care Rehabil. 1989;9:606–609
  25. Poon V, Burd A. In vitro cytotoxicity of silver: implication for clinical wound care. Burns. 2004;30(2):140–147
  26. Landsdown A. How safe is silver in wound care?. J Wound Care. 2004;13:131–135

PII: S0305-4179(05)00023-9

doi: 10.1016/j.burns.2004.12.009

Burns
Volume 31, Issue 5 , Pages 562-567 , August 2005

Article Tools